Compare TU & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TU | STE |
|---|---|---|
| Founded | 1993 | 1985 |
| Country | Canada | United States |
| Employees | N/A | 3700 |
| Industry | Telecommunications Equipment | Industrial Specialties |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 21.3B |
| IPO Year | 2000 | 2018 |
| Metric | TU | STE |
|---|---|---|
| Price | $7.95 | $218.04 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 9 |
| Target Price | $10.00 | ★ $262.14 |
| AVG Volume (30 Days) | ★ 5.7M | 607.4K |
| Earning Date | 11-06-2026 | 11-04-2026 |
| Dividend Yield | ★ 13.43% | 1.26% |
| EPS Growth | N/A | ★ 27.90 |
| EPS | N/A | ★ 7.93 |
| Revenue | N/A | ★ $5,935,900,000.00 |
| Revenue This Year | N/A | $7.35 |
| Revenue Next Year | $0.52 | $6.36 |
| P/E Ratio | ★ $25.82 | $27.61 |
| Revenue Growth | N/A | ★ 8.73 |
| 52 Week Low | $7.64 | $195.14 |
| 52 Week High | $15.41 | $269.44 |
| Indicator | TU | STE |
|---|---|---|
| Relative Strength Index (RSI) | 34.67 | 54.58 |
| Support Level | N/A | $216.22 |
| Resistance Level | $10.11 | $220.39 |
| Average True Range (ATR) | 0.20 | 3.98 |
| MACD | 0.01 | 1.64 |
| Stochastic Oscillator | 36.17 | 67.83 |
Telus is one of Canada's Big Three telecom service providers, offering wireless and broadband services nationally, but with strongholds in British Columbia and Alberta. The firm serves 10 million postpaid and prepaid wireless customers. It counts nearly 3 million broadband customers across a network footprint that passes more than 4 million homes. The firm operates two additional segments, Telus Health and Telus Digital. Telus Health covers 170 million individuals, offering preventive medicine and virtual care in 200 countries. Telus Digital primarily offers third-party customer support, online content moderation, and data transformation.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.